Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Alamar Biosciences, Inc. | ALMR | 110K | $2.98M |
Teva Pharmaceutical Industries Limited | TEVA | 200K | $6.78M |
Phathom Pharmaceuticals, Inc. | PHAT | 200K | $2.17M |
SCYNEXIS, Inc. | SCYX | 260.21K | $1.06M |
Aktis Oncology, Inc. | AKTS | 484.2K | $15.61M |
Vir Biotechnology, Inc. | VIR | 519.3K | $5.29M |
Enliven Therapeutics, Inc. | ELVN | 550K | $27.91M |
Immunic, Inc. | IMUX | 669.94K | $10.3M |
Oruka Therapeutics, Inc. | ORKA | 760.42K | $72.37M |
CG Oncology Inc. | CGON | 1.4M | $99.4M |
Jade Biosciences, Inc. | JBIO | 1.7M | $37.79M |
Dianthus Therapeutics, Inc. | DNTH | 2.1M | $205.12M |